Categories AlphaGraphs, Earnings, Health Care
Key highlights from CVS Health (CVS) Q2 2020 earnings results
CVS Health Corporation (NYSE: CVS) reported second quarter 2020 earnings results today.
Total revenues increased 3% to $65.3 billion, driven by growth across all segments.
The COVID-19 pandemic negatively affected results in the Pharmacy Services and Retail/LTC segments as new therapy prescriptions dropped due to lower provider visits.
Net income grew 54.6% to $2.9 billion, or $2.26 per share. Adjusted EPS totaled $2.64.
CVS raised its GAAP EPS guidance range to $5.59-5.72 from $5.47-5.60 and adjusted EPS guidance range to $7.14-7.27 from $7.04-7.17.
Past Performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
NFLX Stock: Should you invest in Netflix ahead of upcoming earnings?
For a large number of people, streaming videos and TV shows are the first preference when they want to keep themselves engaged during the lockdown. Streaming giant Netflix, Inc. (NASDAQ:
Earnings: Citigroup (C) Q4 profit beats estimates; revenue edges up
Citigroup Inc. (NYSE: C) on Friday said its fourth-quarter profit decreased despite modest growth in revenues. However, the numbers topped the market’s projections. Fourth-quarter net profit declined to $3.2 billion
JPM Earnings: All you need to know about JPMorgan Chase’s Q4 2021 earnings results
JPMorgan Chase & Co. (NYSE: JPM) reported fourth-quarter 2021 earnings results today. Reported revenue was flat year-over-year to $29.3 billion. Net income decrease 12% to $12.1 billion while EPS decreased
